EPHX2 and type 2 diabetes mellitus: Both the gene deletion and pharmacological inhibition of EPHX2 result in the preservation of islet cells in rodent models of type 1 diabetes and an increase in insulin sensitivity in type 2 diabetes (T2D) models, as does the direct administration of EETs [4].